GlaxoSmithKline News and Research

RSS

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006

New bird flu vaccine promises to offer cross-protection

Early clinical trials of a new bird flu vaccine have produced promising results and a phase 3 trial of the cell-based H5N1 flu vaccine is expected to take place early next year.

4 Oct 2006

GSK seeks regulatory approval in U.S., Europe for Tykerb

GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.

20 Sep 2006

GSK to supply antiretroviral drugs to Russia at discounted price

GlaxoSmithKline has announced it would supply 90,000 packs of its antiretroviral drugs Combivir, Epivir and Ziagen to Russia at discounted prices by the end of 2006, the AFP/Yahoo! U.K and Ireland reports (AFP/Yahoo! U.K and Ireland, 9/15).

18 Sep 2006

SSRIs associated with severe violence in a small number of individuals

Use of one class of antidepressant drugs, the SSRIs (selective serotonin reuptake inhibitors), may be associated with severe violence in a small number of individuals say the authors of paper published in PLoS Medicine.

12 Sep 2006

GlaxoSmithKline settles dispute with IRS

GlaxoSmithKline has announced that it has settled its transfer pricing tax dispute with the US Internal Revenue Service (IRS).

12 Sep 2006

Morphotek granted two European technology patents

Morphotek has announced that the European Patent Office has given a "Decision of Grant" regarding the Company's US Patent 6,921,666 entitled "Methods for Generating Hypermutable Yeast" and US Patent 6,737,268 entitled "A Method for Generating Genetically Altered Antigens."

30 Aug 2006

History of cervical cancer, HPV vaccine development

The New York Times on Tuesday examined the development of vaccines to prevent transmission of the human papillomavirus, which can cause cervical cancer.

30 Aug 2006

AIDS vaccine still long way off

Researchers are optimistic about a potential HIV/AIDS vaccine, even though none of the vaccines in development is likely to completely protect people from HIV transmission, participants at the XVI International AIDS Conference in Toronto said at a news conference Tuesday, Reuters reports.

16 Aug 2006

FDA approves next seasons flu vaccines

The Food and Drug Administration (FDA) has announced that it has approved this year's seasonal influenza (flu) vaccines that include the new strains of virus judged likely to cause flu in the Northern Hemisphere in 2006-2007.

2 Aug 2006

Super blackcurrants with boosted vitamin C

Scientists are working with the company behind the fruit drink Ribena to boost the vitamin C content of blackcurrants in a move that would be a major benefit to UK consumers and farmers.

1 Aug 2006

New bird flu vaccine has 80% protection rate

According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.

26 Jul 2006

GSK reports significant advance in H5N1 pandemic flu vaccine programme

GlaxoSmithKline (GSK) today announced headline data showing that its H5N1 pandemic flu vaccine achieved a high immune response at a low dose of antigen.

26 Jul 2006

Vaccines for preventing influenza in the elderly

Although national and international health organizations urge anyone over age 65 to get yearly flu shots, the vaccinations are only modestly effective in preventing flu and its complications among older adults, according to a new review of recent studies.

19 Jul 2006

Ranbaxy to acquire the Mundogen generic business from GlaxoSmithKline

Ranbaxy, India's largest pharmaceutical company, and among the top ten generic pharmaceutical companies in the world, announced today that the Company has acquired the Mundogen generic business of GlaxoSmithKline.

19 Jul 2006

Anti-herpes drug reduces need for Caesarean sections in infected women

Giving an anti-viral drug to pregnant women who have a history of genital herpes significantly lowers the rate of Caesarean sections needed to protect the infant from becoming infected with the virus, researchers at UT Southwestern Medical Center have found.

11 Jul 2006

Media coverage of obesity outweighs smoking cessation stories

Obesity is grabbing more headlines, but not necessarily crowding out media coverage of the dangers of tobacco use, according to a new study sponsored by a drug company. However obesity made more news while tobacco got less attention, based on an analysis of eight years of medical stories in the media.

5 Jul 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

Study contradicts USA warning that an antidepressant can cause congenital abnormalities

A study carried out by German researchers has failed to show that a popular antidepressant, paroxetine, causes congenital abnormalities if taken by pregnant women, the 22nd annual conference of the European Society of Human Reproduction and Embryology heard.

19 Jun 2006

Menopausal women don't get enough guidance on treatment options

Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.

18 Jun 2006